Home › Tumor sa Utak › North Carolina › Durham
Pag-aaral pangklinika para sa Tumor sa Utak sa Durham, NC
14 pag-aaral para sa Tumor sa Utak ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Durham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Nagre-recruitPhase 2
- Local Institution - 0100, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Nagre-recruitPhase 1/2
- Duke University School of Medicine, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- Duke Cancer Institute, Durham
Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
- Duke University Health System, Durham
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Nagre-recruitPhase 2
- Duke University, Durham
Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
- Duke University Health System, Durham
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Nagre-recruitPhase 1
- Duke University Medical Center, Durham
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
Nagre-recruitObservasyonal na pag-aaral
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mi ang layo
B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
Nagre-recruit
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nagre-recruitPhase 2
- Duke University Health System, Durham
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Nagre-recruitPhase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Nagre-recruitObservasyonal na pag-aaral
- Duke University, Durham
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Nagre-recruitObservasyonal na pag-aaral
- Duke Cancer Center, Durham
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
Pag-aaral para sa Tumor sa Utak sa ibang lungsod
- Houston, TX35 pag-aaral
- Boston, MA28 pag-aaral
- New York City, NY25 pag-aaral
- Washington, DC21 pag-aaral
- Los Angeles, CA16 pag-aaral
- Miami, FL15 pag-aaral
- St. Louis, MO12 pag-aaral
- Rochester, MN12 pag-aaral
- Seattle, WA11 pag-aaral
- Chicago, IL11 pag-aaral
- Columbus, OH11 pag-aaral
- Baltimore, MD11 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso63 pag-aaral
- Kanser (lahat ng uri)59 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Baga32 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.